The Birth Control Drug Yaz (Yasmin) Increases Risk of Blood Clots
Yaz/Yasmin / Ocella (drosperinone & ethinyl estradiol) is a hormonal contraceptive administered orally to prevent pregnancy. The Food and Drug Administration (FDA) has also approved the drug for treatment of premenstrual dysphoric disorder and moderate acne. The drug brings with it, however, an increased risk of potentially deadly blood clots. These clots pose a potentially life threatening risk because they can travel through the body’s circulatory system and cause severe damage to the brain, heart and lungs, leading to heart attack, stroke and pulmonary embolism. Clearly, the drug could cause death.
Research has also confirmed the Yaz / Yasmin / Ocella can cause hyperkalemia, an elevated level of potassium in the blood. In severe cases, hyperkalemia can cause cardiac artythmia and sudden death.
The drug’s manufacturer, Bayer HealthCare Pharmaceuticals Inc., has twice received warning letters from the U.S. Food and Drug Administration for failing to warn consumers of the dangers associated with the drug. In October 2008, the FDA sent Bayer a warning letter in response to television commercials promoting Yaz. The commercials, according to the letter, violated the Federal Food, Drug and Cosmetic Act by minimizing the “serious risks associated with use of the drug.” Additionally, the commercials suggested Yaz could be used to treat symptoms of Premenstrual Syndrome, a treatment for which the drug was not granted approval by the FDA. In March 2009, the FDA again wrote to Bayer concerning advertisements that failed to warn consumers of dangers associated with Yaz / Yasmin / Ocella.
If you or a loved one has been hurt as a result of using Yaz, you may be entitled to financial compensation. Call Tim Edwards and Ed Wallis for help with your Tennessee, Arkansas, Mississippi or beyond free factual case evaluation by:
CALL: (901) 527-2125
AFTER HOURS/WEEKENDS: (901) 275-0600
EMAIL: Tim or Ed by clicking here
FILL OUT THIS FORM FOR FREE HELP:
